Table 4 Expert perspectives on the implementation barriers for introducing of TACTs in Southeast Asia
Implementation barriers | Explanation | n |
|---|---|---|
Intensified prescriber training | Intensifying training requirements for correct TACTs prescription | 27 |
Donor funder support | Obtaining support by donor funders to cover TACTs implementation costs and potential price increases | 24 |
National policy support | Obtaining support from national malaria control programs and other national decision makers | 24 |
WHO and global policy support | Obtaining support from the WHO and other global decision makers | 19 |
Availability of fixed-dose combination (FDC) TACTs | Ensuring timely development and production of fixed-dose combination (FDC) for TACTs | 17 |
Community acceptance | Ensuring community acceptance by providing clear communication and tackling potential misconceptions about TACTs | 12 |
Collecting safety and efficacy data | Collecting sufficient efficacy and safety data to support the introduction of TACTs | 11 |
Supply chain logistics | Adapting import, procurement and supply routes for the introduction of TACTs | 11 |
Regulatory approval | Obtaining timely regulatory approval for introducing TACTs in Southeast Asia | 11 |
Set up surveillance systems | Setting up surveillance systems to monitor drug resistance and adherence to TACTs | 9 |
Private sector engagement | Engaging the (informal) private sector in TACTs deployment and creating demand beyond official programs | 5 |
Set up pharmacovigilance systems | Setting up a pharmacovigilance system for TACTs | 4 |
Stockpile management | Managing stockpiles for countries that still have ACT stocks or contract deals with ACT producers | 3 |